EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma

Similar Items

• EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics
  od: Arcila, Maria E, i dr.
  Izdano: (2013)
• EGFR exon 20 insertions in advanced lung adenocarcinomas: clinical outcomes and response to erlotinib
  od: Naidoo, J, i dr.
  Izdano: (2015)
• Response heterogeneity of EGFR and HER2 exon 20 insertions to covalent EGFR and HER2 inhibitors
  od: Kosaka, Takayuki, i dr.
  Izdano: (2017)
• Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions
  od: Oxnard, Geoffrey R., i dr.
  Izdano: (2013)
• Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions
  od: Choudhury, Noura J., i dr.
  Izdano: (2021)